Article

Treatment delay associated with alternative medicine use among veterans with head and neck cancer

Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, Washington, USA.
Head & Neck (Impact Factor: 3.01). 10/2006; 28(10):926-31. DOI: 10.1002/hed.20420
Source: PubMed

ABSTRACT Use of complementary and alternative medicine (CAM) is increasing in the United States. This study investigates whether the use of alternative medicine is associated with a delay of treatment in head and neck cancer.
This study used the records obtained from a large trial involving ambulatory care US veterans. Subjects completed a CAM utilization questionnaire. The primary outcome variable was the time duration from cancer diagnosis to the time of cancer treatment.
Of veterans with head and neck cancer, 51% reported using some form of CAM, whereas 23% reported using a therapy classified as alternative medicine. Patients who used alternative medicine significantly delayed cancer treatment by 22 days compared with those who did not use alternative medicine (p = .05, 95% confidence interval [CI] = 0-44 days).
CAM use is common in veterans with head and neck cancer. Use of alternative medicine was associated with a significant delay in cancer treatment.

Full-text

Available from: Greg E Davis, May 25, 2015
0 Followers
 · 
152 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction Complementary and Alternative Medicine (CAM) is being increasingly used across the general population, with much attention drawn to the direct health risks associated with rising CAM use–particularly in respect to efficacy and drug-herb interaction. However the potential for other forms of risk associated with increased CAM use has received far less attention. This review article provides the first broad overview and appraisal of potential non-health and indirect health risks associated with CAM use. Methods A comprehensive search of literature from 2000 to 2011 in CINAHL, MEDLINE, AMED, and EMBASE was conducted. The search was confined to peer-reviewed articles published in English reporting non-health and indirect health risks associated with CAM. Results The review identifies a number of non-health risks associated with CAM use. These can be broadly categorised as risks due to variability; risks due to assumption; risks due to opportunity costs; economic risks, and risks due to unorthodoxy. Indirect and non-health risks may also compound or exacerbate existing direct risks associated with CAM treatment. Conclusion In order to fully appreciate and appraise the relative merits of CAM practice and provision, researchers need to be mindful that a range of potential risks (beyond direct health risks) may be associated with CAM use. Adequate regulatory and policy frameworks need to be put in place to ensure that these risks are minimised.
    European Journal of Integrative Medicine 08/2014; 6(4). DOI:10.1016/j.eujim.2014.01.001 · 0.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Delayed reporting resulting in advanced stage disease is a common problem in Indian cancer patients. This study analysed the impact of various sociodemographic and psychosocial factors on the delayed reporting to Healthcare Professional (HCP) in oral and oropharyngeal cancer patients.
    International journal of preventive medicine 07/2014; 5(7):915-919.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to determine the use of complementary and alternative medicine (CAM) among cancer patients in Malaysia. A cross-sectional study was carried out among cancer patients at two Malaysian referral hospitals. The questionnaire consisted of 28 items includes patients’ socio-demographic characteristics, clinical characteristics and questions about CAM use. A total number of 200 cancer patients participated in this study. The majority were female, Malay, married, with tertiary education and working (54.5%, 36.5%, 53.5%, 46.5%, 45.0%; respectively). The majority were in stage 2 and diagnosed with cancer 1 to 2 years ago (47.5%, 37.5%; respectively). The prevalence of CAM used among the study participants was found to be 14%. The majority of them used the CAM during the treatment (72.7%), used the CAM less than six months (37.0%). The majority of cancer patients reported that CAM is beneficial for them and there is no side effect of CAM and they were satisfied with CAM (65.5%, 92.0%; 80.0%; respectively). Only few patients stopped conventional treatment while using CAM (14.5%). Relieve pain (19.5%) and relieve the symptoms (16.5%) were the reasons for CAM used. The most popular CAM used among cancer patients was sea cucumber (22%) and homeopathy (10.5%). The least popular CAM used reported by the study participants was green tea (0.5%). Level of education found to be significantly influence the use of CAM among cancer patients in this study. In light of the growing interest in CAM, health-care professionals need to be educated about the most common CAM therapies used among cancer patients. This study reported a new finding that 16.4% of cancer patients stopped the standard treatment while using CAM. This is a serious problem and should be addressed and further intervention studies needed.
    World Journal of Medical Sciences 04/2013; 8(2):157-164.